15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Leadless pacemaker implantation in a subpulmonic left ventricle in a patient with congenitally corrected transposition of the great arteries

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction Leadless pacemakers are designed for implantation in a subpulmonic, morphologic right ventricle in patients with normal cardiac anatomy. In selected scenarios the subpulmonic ventricle may be a morphologic left ventricle. We present a case of a 38-year-old male patient with congenitally corrected transposition of the great arteries (ccTGA) with complete heart block who developed a pocket infection after implantable cardioverter-defibrillator (ICD) implantation. He had significant superior vena cava (SVC) stenosis, making vascular access for future lead placement difficult. An AV MicraTM (Medtronic Inc., Minneapolis, MN) leadless pacemaker was successfully implanted in his subpulmonic left ventricle. Case report The patient is a 38-year-old man with ACHD-AP (Adult Congenital Heart Disease Anatomic and Physiologic) class IIIC adult congenital heart disease with ccTGA and dextrocardia, born with a malalignment conal ventricular septal defect, membranous ventricular septal defect, infundibular and pulmonic stenosis, subvalvular aortic stenosis, and double outlet right ventricle. Initial corrective surgery at age 8 included aortic homograft placement from the subpulmonic left ventricle to pulmonary artery and closure of ventricular septal defects. He developed complete heart block during the surgery and had a permanent transvenous ventricular pacemaker placed prior to discharge. He developed severe tricuspid insufficiency with right systemic ventricle dysfunction as well as left subpulmonic ventricle–to–pulmonary artery conduit stenosis. This required reoperation and placement of mechanical tricuspid and pulmonary valves at age 16. He also had placement of a dual-chamber epicardial pacemaker system at that time and explantation of prior transvenous system. Two years later, he required a new atrial lead, resulting in creation of a hybrid pacemaker with a transvenous atrial lead and epicardial ventricular lead. There was debate about designating his anatomy as mesocardia or dextrocardia, but imaging reliably showed a cardiac apex pointed rightward, consistent with dextrocardia. Eight years later, at age 26, the patient underwent pacemaker generator change for elective battery replacement indication. Six years later, at age 32, he underwent another generator change owing to reaching elective battery replacement indication. Four years later, at age 36, he had nonsustained polymorphic ventricular tachycardia and malfunction of the epicardial right ventricular pacing lead with intermittent lead noise. With this lead fracture, he was referred for device revision. He had developed a severely dilated systemic right ventricle with poor function, yet remained in NYHA class II heart failure and was working full-time. He was referred for implantable cardioverter-defibrillator (ICD) placement owing to a single, asymptomatic run of polymorphic ventricular tachycardia, nonischemic cardiomyopathy, and complete heart block. He had a single-chamber transvenous ICD implanted on therapeutic warfarin, given his mechanical valves. The ICD lead was anchored to the left ventricular, subpulmonic endocardium. This procedure was prolonged owing to difficulty advancing the lead through the SVC and manipulating the lead in the left ventricle. Given the prolonged procedural time, a TYRX antimicrobial pouch was used to reduce his risk for infection. The permanent pacemaker was left in place, as he was on therapeutic anticoagulation (international normalized ratio 2.5) during the case. He unfortunately presented with an infected ICD pocket 3 months later. The patient had explantation of the transvenous ICD system and pacing system using a 12F laser and 11F cutting sheath. The permanent pacemaker was also removed because the course of the atrial lead was superimposed to the infected pocket. Evidence of SVC stenosis at the right atrial junction was confirmed during the extraction (Figure 1A). A temporary-permanent pacer was placed via the right internal jugular vein through the SVC for a period of 4 days until cultures were confirmed negative while the patient was on intravenous antibiotics. The significant SVC/ right atrium stenosis presented a therapeutic challenge for placement of future transvenous leads, with risk of SVC syndrome. Figure 1 A: Left anterior oblique (LAO) 30° view showing significant superior vena cava stenosis (black arrow), as seen on venography during implantable cardioverter-defibrillator lead extraction. B: LAO 20° view showing the AV Micra (Medtronic Inc., Minneapolis, MN) deployed against the left ventricular septum without difficulty in securing its position. A decision was made to implant a leadless pacemaker, and not a transvenous ICD, given difficult vascular access, pacemaker dependence, and recent infection. Although there was risk of pacing-induced cardiomyopathy, dual-chamber pacing was not an immediate option and an AV Micra was chosen. The procedure was performed on therapeutic warfarin, given his 2 mechanical valves. A quadripolar catheter was placed in the subpulmonic left ventricle for back-up pacing via the left femoral vein. An 8F sheath was placed in the right femoral vein and upsized to a 27F Micra sheath. Heparin (5000 units) was administered. The sheath was maneuvered from the right atrium to the left ventricle. The Micra was positioned against the left ventricular septum (Figure 1B). Multiple “tug” tests were performed and at least 3 tines were secured to the endocardium before the device was deployed. The mode was set to VVIR with threshold 0.3 V, pulse width 0.2 ms, and resistance 710 ohms. There were no issues with capture or attachment (Figure 2). Figure 2 Electrocardiogram post Micra (Medtronic Inc., Minneapolis, MN) implant showing a ventricular-paced rhythm with underlying atrial fibrillation. The patient was later screened for a subcutaneous ICD, but was deemed not to be a candidate owing to large T waves in the paced complexes. A transvenous ICD was not actively reconsidered, as the patient did not have new sustained ventricular tachycardia on pacemaker monitoring, nor did he have syncope or cardiac arrest. The patient has had limited follow-up since Micra implant due to no-showing appointments. Remote device interrogation 6 months postimplant revealed normal device function without any episodes of ventricular arrhythmia and 98% pacing. Pacing and sensing thresholds were similar to 1 month postimplant measurements. Discussion Adult congenital heart disease patients with complex anatomy often have conduction abnormalities requiring hardware implantation for pacing and defibrillation. From our review, this is only the second reported case of a Micra leadless pacemaker implanted in a patient with dextrocardia and the first in a morphologic left ventricle serving as the subpulmonic ventricle. In this case, the patient has congenitally corrected transposition (l-transposition), but patients with d-transposition of the great vessels after atrial baffle surgery may also have similar issues with venous stenosis and pacing needs. There is 1 prior report of Micra implantation in the morphologic left ventricle in a patient with a univentricular heart. 1 Patients with ccTGA have discordant atrioventricular and ventriculoarterial anatomy. ccTGA is a rare form of congenital heart disease, with an incidence of 1 in 33,000 live births. 2 The position of the atrioventricular node(s) and course of the bundle branch fibers often vary with patients’ unique anatomy in ccTGA. 3 As a result, these patients are known to have abnormal atrioventricular node function and up to half may develop AV block, with about 30% developing complete heart block. In a series of 107 patients, there was a 2% per year risk of progressing to complete heart block after diagnosis. 4 In addition to having complex congenital heart disease, our patient is one of many who developed complications from an implantable device. Implantable pacemakers and implantable device complications are well studied. About 12% of patients experience complications within 2 months, and pocket-related complications account for about 5% of complications. 5 A possible solution for patients who are poor candidates for transvenous systems are the evolving leadless devices. Leadless pacemaker systems are expanding in their scope and ability to provide right and left ventricular endocardial pacing in adults and children. 6 , 7 Micra systems have not been associated with significant risk of infection and have an overall lower complication rate than conventional pacemakers. 8 Leadless pacemaker retrieval, either Nanostim or Micra, has been shown to be both feasible and safe. 9 Leadless pacemaker placement in unconventional scenarios has also been described and is important to consider in complex patients. 10 The Micra Transcatheter Pacing System was designed for implantation in the right ventricle, with tissue penetration properties characterized from human hearts. Device implantation testing was performed in the right ventricular apex and right ventricular outflow tract in preclinical trials. 11 In this present case, the pacemaker was implanted in the morphologic left ventricle secondary to ccTGA. There has not been an evaluation of differences in pacing thresholds and fixation characteristics for left ventricular endocardial pacing for Micra devices. There are differences in the embryology and gene expression between the left and right ventricle, reflected as differences in histology, anatomy, and conduction properties. 12 In patients with normal anatomy, in comparison to the left ventricle, the subpulmonic right ventricle has thinner myocardium and is more compliant. The right ventricle also has coarser trabeculae than the left ventricle (Figure 3). Left ventricle endocardial pacing via transvenous leads has been shown in limited studies to be feasible and effective. 13 In this case, the tine deployment of the Micra TPS behaved the same way as a typical right ventricular device placement. Unfortunately, the patient was not a candidate for a transvenous ICD or subcutaneous ICD at this time. Figure 3 Anatomic section from a patient with congenitally corrected transposition of the great arteries (A and B) compared to a normal heart (C). A: Four-chamber view with the right atrioventricular valve located cephalad to the atrioventricular valve. B: Long-axis view with the arrow pointing to the coronary sinus ostium. C: Typical trabeculation in a morphologic right ventricle with multiple Micras (Medtronic Inc., Minneapolis, MN) implanted. CS = coronary sinus; LA = left atrium; LV = morphologic left ventricle; PA = pulmonary artery; RA = right atrium; RV = morphologic right ventricle. Used with copyright permission. 14 , 15 Patients in the congenital heart disease population often have complex anatomy and complex medical histories that make the use of alternative pacing systems attractive. Further research needs to be done to fully characterize attachment and conduction properties of leadless pacemakers in morphologic left ventricles. However, this experience with implanting a Micra transcatheter pacemaker in a subpulmonic, morphologic left ventricle may allow us to consider leadless pacing therapy in patients with ccTGA or in d-transposition post atrial switch, where the left ventricle serves as the subpulmonic ventricle. Key Teaching Points • Patients with congenitally corrected transposition of the great arteries (ccTGA) are predisposed to developing heart block. • Patients with ccTGA and conduction abnormalities have a unique circumstance where device leads must be implanted in a morphologic left ventricle. • Implantation of a leadless pacemaker in a morphologic but subpulmonic left ventricle was shown to be feasible.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study.

          Today quantitative information about the type of complications and their incidence during long-term pacemaker (PM) follow-up is scarce. To assess the incidence and determinants of short- and long-term complications after first pacemaker implantation for bradycardia. A prospective multicenter cohort study (the FOLLOWPACE study) was conducted among 1517 patients receiving a PM between January 2003 and November 2007. The independent association of patient and implantation-procedure characteristics with the incidence of PM complications was analyzed using multivariable Cox regression analysis. A total of 1517 patients in 23 Dutch PM centers were followed for a mean of 5.8 years (SD 1.1), resulting in 8797 patient-years. Within 2 months, 188 (12.4%) patients developed PM complications. Male gender, age at implantation, body mass index, a history of cerebrovascular accident, congestive heart failure, use of anticoagulant drugs, and passive atrial lead fixation were independent predictors for complications within 2 months, yielding a C-index of 0.62 (95% confidence interval 0.57-0.66). Annual hospital implanting volume did not additionally contribute to the prediction of short-term complications. Thereafter, 140 (9.2%) patients experienced complications, mostly lead-related complications (n = 84). Independent predictors for long-term complications were age, body mass index, hypertension, and a dual-chamber device, yielding a C-index of 0.62 (95% confidence interval 0.57-0.67). The occurrence of a short-term PM complication was not predictive of future PM complications. Complication incidence in modern pacing therapy is still substantial. Most complications occur early after PM implantation. Although various patient- and procedure-related characteristics are independent predictors for early and late complications, their ability to identify the patient at high risk is rather poor. This relatively high incidence of PM complications and their poor prediction underscores the usefulness of current guidelines for regular follow-up of patients with PM. Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Cardiac Conduction System in Congenitally Corrected Transposition of the Great Arteries and Its Clinical Relevance

            Introduction Congenitally corrected transposition of the great arteries (ccTGA) is a rare cardiac malformation characterized by the combination of discordant atrioventricular and ventriculoarterial connections.1 The incidence has been reported to be around 1/33 000 live births, accounting for ≈0.05% of congenital heart malformations.2 Although a familial recurrence of heart defects in subjects with ccTGA has been reported,3 the etiology of this malformation is not currently known.1, 4 The morphological right atrium is connected to the morphological left ventricle across the mitral valve, with the left ventricle then connected to the pulmonary trunk; the morphological left atrium is connected to the morphological right ventricle across the tricuspid valve, with the morphological right ventricle connected to the aorta. Because of this “double discordance,” the systemic venous return is pumped to the lungs, while the pulmonary venous return is directed to the body. In the context of usual atrial arrangement (situs solitus), the morphological left ventricle is thus positioned to the right and the aorta, arising from the morphological right ventricle, is more commonly left‐sided. In mirror‐image atrial arrangement (situs inversus), the morphological left ventricle is left‐sided, and the aorta is usually positioned to the right. Most patients have at least 1 associated cardiac anomaly, mainly ventricular septal defect (VSD), subvalvular and/or valvular pulmonary stenosis, or abnormalities of the systemic (tricuspid) atrioventricular (AV) valve with coexisting accessory pathways.4 Because of the unusual position of the atrioventricular node and course of the atrioventricular conduction bundle, cardiac conduction disorders are frequent and markedly alter the natural history and management of the malformation.5, 6, 7 This article provides a comprehensive, up‐to‐date description of the characteristics of the cardiac conduction system in patients with ccTGA, their clinical sequelae, and their contemporary management. Morphology and Cardiac Conduction System in ccTGA Most commonly, there is the usual atrial arrangement. The heart position in the chest is usually normal or midline or occasionally right‐sided. The morphologic right ventricle is often to the left and slightly anterior position or is directly to the left of the morphologic left ventricle in the setting of a vertically oriented septum. Compared with normal hearts, the morphologic right atrium may bear features relevant to interventions such as a displaced coronary sinus orifice, a short isthmus, and a short posterior rim of the oval fossa.8 The anatomical disposition of the cardiac conduction system is different in the 2 forms of congenitally corrected transposition: those with the usual atrial arrangement versus those with mirror‐imaged arrangement of atrial appendages, and there are important deviations to note (Figure 1). Figure 1 Disposition of the atrioventricular conduction system in ccTGA in usual atrial arrangement (situs solitus, top panel) or in mirror‐image arrangement (situs inversus, bottom panel). Ao indicates aorta; ccTGA, congenitally corrected transposition of the great arteries; PT, pulmonary trunk. Hearts with the usual atrial arrangement have a grossly abnormal disposition of the atrioventricular conduction system (Figure 1).9 Due to the deeply seated pulmonary outflow tract in between the ventricular septum and the mitral valve, there exists a malalignment gap between the ventricular septum and the atrial septum. The gap is filled by a large membranous septum or is occupied by a large perimembranous VSD. Consequently, a regularly situated posterior atrioventricular node is hypoplastic and cannot connect with any atrioventricular bundle. Instead, there is an anterior atrioventricular node located below the orifice of the right atrial appendage close to the lateral margin of the area of fibrous continuity between pulmonary and mitral valves. This anomalous node gives origin to the penetrating bundle of His that pierces though the fibrous trigone to continue as the atrioventricular bundle in the subendocardium of the ventricular myocardium, along the cephalad margin of the outflow tract, in the immediate subpulmonary area adjoining the pulmonary leaflets. As it reaches the ventricular septum, the bundle turns inferiorly to descend anteriorly along the septum for some length before it branches to give the left bundle branch on the right side and the right bundle branch on the left side (Figure 2). In the presence of a VSD the atrioventricular bundle is related to the defect's anterior margin, usually on the right side just off the septal crest. Figure 2 Disposition of cardiac conduction system in ccTGA. Ao indicates aorta; AV, atrioventricular; ccTGA, congenitally corrected transposition of the great arteries; cs, coronary sinus; LBB, left bundle branch; LV, left ventricle; PT, pulmonary trunk; RA, right atrium; RBB, right bundle branch; RV, right ventricle; VSD, ventricular septal defect. By contrast, in the mirror‐imaged atrial arrangement, the sinus node is located in the left‐sided atrium in its usual position in relationship to the terminal crest and the entrance of the superior caval vein. In these hearts the atrial and ventricular septa are better aligned, allowing a regularly located atrioventricular node, at the apex of the triangle of Koch, to continue in normal fashion to an atrioventricular bundle that passes in a posteroinferior relationship to the margin of a VSD if there is one.10 The bundle branches descend in usual fashion with the cord‐like right bundle branch to the right side of the septum and the fan‐like left bundle branch to the left side. After giving the bundle branches, the branching bundle may continue as an anterior bundle that ends blindly, not making contact with another atrioventricular node that is situated anteriorly.11 There are, however, exceptions or variations to this template for hearts with the usual atrial arrangement. In cases where the pulmonary outflow tract is atretic or narrowed, septal malalignment is reduced. In these, histologic studies of a few cases have shown a sling of atrioventricular conduction system connected to both anteriorly and posteriorly situated atrioventricular nodes.9, 12 In others, although there are 2 nodes, there is no sling. The anterior node connects with an anterior bundle.9 Reported variations include a case with 3 atrioventricular nodes in a heart that had an accessory pathway in the left‐sided tricuspid annulus12 and a rare case of straddling of the mitral valve across a large perimembranous defect, which on histologic examination revealed a regularly positioned posterior node and bundle.13 Cardiac Conduction Disorders in ccTGA Etiology The etiology of conduction disease in ccTGA directly relates to the underlying developmental anatomical anomalies. In the absence of associated malformations, the patient may be without symptoms, remaining undiagnosed for many years and only presenting much later in life with progressive heart block, which is attributed to fibrotic changes leading to complete discontinuity of the abnormally long atrioventricular conduction bundle.14 Heart block may also present in infancy. The study of the conduction system by Lev and colleagues in 196315 is probably the earliest to document congenitally complete atrioventricular block. In a small series of patients, complete atrioventricular block was seen in 15 of 30 cases with normal atrial arrangement but not in any of 8 cases with associated situs inversus.16 Furthermore, cases with 2 AV nodes may be seen with penetrating conduction bundles that join to form a sling typically around a VSD, as first described by Monckeburg in 1913. This arrangement is classically seen in cases with the combination of atrial isomerism, an atrioventricular septal defect, and ccTGA. Perioperative AV block may occur with either physiologic or anatomic correction,17 and transient AV block may also be induced by cardiac catheterization.18 Electrocardiographic and Electrophysiologic Features The ECG appearance relating to ventricular activation in ccTGA is different from that seen in the structurally normal heart. As the right and left conduction bundles relate anatomically to the respective ventricles, septal activation occurs in the opposite direction, namely from right to left.4 This leads to a mirror image pattern in the precordial leads leading to a reversal of the normal QRS morphology, with Q waves evident in V1 and a dominant R wave but no Q wave in V6. The P‐waves and QRS axis may also vary depending on the specific atrial arrangement and location of the AV node and proximal conducting bundles,19 and further ECG variation may arise from other anatomical anomalies commonly seen in the condition. Manifest ventricular pre‐excitation may also be present and may mask varying degrees of intrinsic conduction disease within the AV node and proximal conducting bundles. This should be especially considered in those with a fully preexcited QRS in the absence of supraventricular tachycardia. Conduction disease may involve either the AV node or the proximal or His bundle as well as the more distal bundle branches. In patients followed sequentially, conduction disease may progress over time, and presentation with complete AV block leading to a diagnosis of ccTGA is well recognized.20 An early study of the electrophysiologic properties in patients with ccTGA and conduction block including first‐degree AV block found variable sites of block occurring in the AV node, the His bundle, and the distal conduction system. In 2 patients with block distal to the His bundle, 1 presented with repeated syncope, and the other died suddenly.7 Clinical Description and Natural History Conduction disease in ccTGA may be apparent at any age from fetal life to late adulthood. From the small numbers of cases reported, the diagnosis of complete AV block in either fetal or early postnatal life does not seem to incur a higher risk of early death.21 A study by Huhta et al reported the annual risk of developing AV block to be 2%.5 In this study the major risk factor for the development of AV block was an intact ventricular septum, with AV block seen in 48% of such patients compared with 13% of those with a VSD. The natural history of conduction disturbances in 17 patients with isolated ccTGA was reported by Daliento et al in 1986.6 Ten patients presented with a normal PR interval and 2 with first‐degree AV block (12%). Five patients had complete AV block (29%), but none had had it at birth, and first‐ and second‐degree AV block preceded complete AV block in 2 patients. One patient died suddenly 24 years after the onset of compete AV block, and histologic investigation disclosed fibrosis and disruption of the proximal nonbifurcating His bundle. However, it was unclear whether death was from complete heart block or an underlying arrhythmogenic myocardial substrate.6 The fundamental cause of morbidity and mortality in ccTGA appears to be more related to a gradual deterioration in systemic right ventricular function.22 The reasons for this are multifactorial in etiology, but increasingly long‐term single‐site ventricular pacing is recognized as a factor.23 Approximately 75% of patients with ccTGA will have other significant structural lesions including varying VSDs, pulmonary stenosis or atresia, and Ebsteinoid malformation of the left‐sided, systemic tricuspid valve, and for that reason surgery is mandated in the vast majority.4 Due to the decreased long‐term survival after conventional (physiologic) surgical repair, a more anatomic surgical approach has been adopted to recruit the morphologic left ventricle to the systemic circulation.24 Anatomic correction involves an atrial switch (Mustard or Senning procedure) coupled with the arterial switch, or a Rastelli procedure in those with a VSD and pulmonary atresia. Although no prospective comparative study will ever be performed, overall there seems to be no major benefit from an anatomic surgical approach in relation to long‐term survival of the intrinsic AV conduction system.25, 26 Management of Conduction Disorders in ccTGA Follow‐Up Modalities Approximately 10% of individuals with ccTGA present initially with complete AV block and 20% to 30% with first‐ and second‐degree AV block. The risk of surgical AV block related to anatomic repairs of ccTGA is variously reported between 3% and 16% of patients and, based on a meta‐analysis of surgical strategies in ccTGA, is higher in patients undergoing the arterial switch operation (12%) than with the Rastelli procedure. There is also a tendency of AV conduction defects to progress with age, and the incidence of complete AV block in older children and adults with ccTGA is 30% to 38%.5, 27 The risk of developing de novo AV block is ≈2%/y.22 For this reason, patients with ccTGA should be followed closely with annual ECG and ambulatory monitoring (even in the absence of symptoms); and cardiopulmonary stress testing can be useful (class IIa) to detect subtle deterioration in the infranodal conduction tissue that will block with faster heart rates.28, 29, 30 Pacing Indications and Modalities Permanent pacemaker implantation may be indicated in patients with congenital heart disease including ccTGA as recommended in published professional practice guidelines.28, 29, 30, 31 The decision regarding permanent pacemaker therapy must ultimately be made on an individual basis, keeping in mind the fragility of the conduction system. For example, in some ccTGA patients undergoing surgery, it may be prudent to implant prophylactic epicardial pacing leads for future use at the time of a cardiac surgical procedure even if the patient is not in imminent need of pacing, to prevent the need for another sternotomy for the sole purposes of pacing. Cardiac Resynchronization Therapy Indications and Modalities Although pacemaker therapy is essential for maintaining chronotropic competence and cardiac output, reports have demonstrated an association between pacemaker implantation and the deterioration of systemic ventricular function in patients with ccTGA. More specifically, deterioration in systemic right ventricular (RV) function and worsening systemic AV valve regurgitation have been shown to be associated with subpulmonary univentricular (UniV) pacing.23, 32 Potential causes include changes in septal activation causing a septal “shift” and secondary dilatation of the systemic AV annulus with subsequent right AV valve regurgitation.4 Pacing‐induced ventricular dyssynchrony may also play an important role in the functional deterioration of the systemic RV in patients with ccTGA. Some studies have shown that biventricular (BiV) pacing appears to preserve systemic ventricular function in ccTGA patients. Janousek et al initially reported the benefits of cardiac resynchronization therapy (CRT) in a small case series of 8 patients with systemic RV including ccTGA, in whom there was significant improvement in the RV fractional area change (RVFAC) as well as NYHA functional class.33 Recently, Hofferberth et al reported their evolving experience with 53 patients with ccTGA who received primary dual‐chamber UniV pacemakers. Fourteen (26%) patients were upgraded to BiV pacemakers due to systemic ventricular dysfunction, and half of these patients demonstrated subsequent improvement in ventricular function. In the same study, 11 patients underwent primary BiV pacemaker implantation for heart block, and none developed ventricular dysfunction during short‐term follow‐up.32 Similarly, Yeo et al compared 22 ccTGA patients with subpulmonary UniV pacing to a relatively closely matched group of 30 unpaced ccTGA patients and 7 BiV‐paced ccTGA patients. The subpulmonary UniV‐paced patient group demonstrated progressive deterioration in the RVFAC, systemic AV valve regurgitation, and RV dilatation as well as corresponding deterioration in NYHA class compared with the unpaced patient group and the BiV‐paced patient group. The latter group showed improvement in RVFAC despite having lower baseline RVFAC.23 These studies give impetus for further investigation of alternative pacing modalities in ccTGA such as BiV pacing. The response to BiV pacing is likely to be variable and may be influenced by the degree of systemic AV valve regurgitation, myocardial scarring, and type of electrical conduction delay. In a multicenter study by the Working Group for Cardiac Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology, CRT was assessed in 109 pediatric and CHD patients including 36 patients with a systemic RV (ccTGA present in 20 patients). Reverse ventricular remodeling after CRT was significantly greater in patients with systemic left ventricle (LV) compared with those with systemic RV, and the degree of systemic AV valve regurgitation did not improve in subjects with a systemic RV after CRT.34 Rarely, BiV pacing may actually worsen heart failure symptoms and RVFAC. Kiesewetter et al reported 2 cases of ccTGA with subpulmonary UniV pacing, a wide QRS, and heart failure who were upgraded to CRT. After a promising early response to CRT, an adverse response with worsening heart failure and deterioration in ventricular function was encountered in both patients, leading to discontinuation of CRT.35 One of the explanations for the less successful reverse remodeling in patients with systemic RV may be that valvar regurgitation from a structural tricuspid valve is potentially less remediable by CRT than functional mitral regurgitation in a systemic LV. Therefore, it should be emphasized that any strategy aimed at improving RV function in ccTGA patients should ideally also include improving TV significant regurgitation. CRT may also be considered in ccTGA patients with ventricular dysfunction and congestive heart failure without AV conduction abnormalities. However, in general, the benefits of CRT in patients with a narrow QRS are not yet established.36 Therefore, it is unclear whether CRT will be beneficial for ventricular remodeling in ccTGA patients with congestive heart failure without QRS prolongation. From a procedural standpoint, unless patient size, venous obstructions, and residual lesions pose limitations, an entirely transvenous system can be implanted in ccTGA patients for the purposes of CRT. This is in contrast to CRT for patients with d‐TGA after atrial switch procedures in whom access to the systemic RV is usually obtained via a surgical procedure. In ccTGA the coronary sinus develops with the morphologic atria (ie, in the majority of cases the coronary sinus drained into the right atrium), and the venous branches, including the great cardiac vein and lateral branches, develop with the morphologic ventricles. Subsequently, the ventricular veins that drain the morphologic RV tend to be small and short, rarely draining all the way from the RV apex, which makes lead implantation challenging. However, the presence of large Thebesian veins and extensive collateralization between the RV and LV at both anterior and posterior interventricular grooves via the anterior intraventricular vein and middle cardiac vein offer alternative routes for pacing of the morphologic RV anteriorly or posteriorly.37 Alternatively, biV pacing may be performed by surgical placement of epicardial LV and RV pacing leads or with a hybrid approach that involves surgical placement of an epicardial RV pacing lead and transvenous placement of an endocardial LV lead.33, 38 Finally, given the relatively high percentage of ccTGA patients who will undergo either UniV or BiV pacing over their lifetimes, close patient follow‐up and meticulous monitoring of ventricular function are warranted. Essential Considerations for Ablation An in‐depth understanding of the location of the AV node is vital for any supraventricular ablation in patients with any form of congenital heart disease but especially ccTGA. Ablation of typical isthmus‐dependent (cavomitral) flutter is not usually considered higher risk, and ablation can safely be performed in the standard position. Similar to ablation in hearts with normal anatomy, iatrogenic AV nodal block is less likely when the linear lesion is delivered off the septum. AV node reentry tachycardia ablation, however, requires special consideration given that the targets for ablation are the accessory atrionodal inputs—the slow pathways39—and the fast pathway should be avoided. In addition, if more than 1 AV nodal structure is present, multiple permutations of AV node reentry tachycardia are possible, including internodal reentry, and exact definition of the culprit circuit is crucial. Internodal reentry utilizing a Monckeberg‐type sling whereby conduction proceeds anterograde down 1 AV node and His system and retrograde via the other can therefore be excluded by dissociating atrial and ventricular activation (confirming a lack of a 1:1 AV relationship). If, however, this arrhythmia is present, then typically 1 of the AV nodes will require ablation—but only after AV conduction is confirmed to be robust via the other AV nodal structure. As is the case in the normal heart, electrical conduction proceeding into the AV node remains silent, and the exit into atrial tissue from the AV node during tachycardia is visible as the earliest atrial activation. If other mechanisms of supraventricular tachycardia have been excluded using pacing maneuvers, and the earliest activation appears on the septum in the conventional position for the fast pathway (behind the Tendon of Todaro), then empiric, anatomically guided slow pathway ablation should be undertaken. In the situation of twin AV nodes the culprit AV node will need to be defined using resetting or subthreshold stimulation so as to identify the adjacent slow pathway to be targeted40, 41 and robust anterograde conduction via the other AV node confirmed with pacing outside of tachycardia. More commonly, anterograde conduction proceeds via the anterior AV node, and the safest empiric approach will involve ablation in the right posteroseptum in the standard location, observing closely for junctional beats and monitoring AV conduction. Unsuccessful empiric ablation here suggests that the likely culprit slow pathway is either left‐sided or involves the anterior AV nodal inputs. A stepwise approach to ablation of these slow pathways can then be considered, with the safest initial target being the left‐sided slow pathway if the operator is convinced this is not the fast pathway. The anterior AV nodal slow pathway can be targeted with ablation in the root of the pulmonary artery, pursuing atrial signals visible along the posterior aspect of the pulmonary artery cusps while also closely monitoring AV conduction (Figure 3).39 As a corollary to this, any ablation being undertaken near the pulmonary valve runs the risk of injury to the fragile His, which courses directly behind this structure, and the operator needs to exercise extreme caution. Figure 3 Illustration depicting the cardiac conduction system in some patients with ccTGA in whom 2 AV nodes and His bundles are present. The atrionodal connections to the posterior AV node occur via the usual slow and fast pathway locations. Atrial tissue interfaces with the anterior AV node from the usual fast pathway region but also from above the pulmonary valve along the pulmonary cusps. Ablation for elimination of AV nodal reentrant tachycardia entails defining the circuit, followed by safely targeting of the culprit slow pathway while avoiding both the fast pathway and AV nodal tissue. Ao indicates aorta; AV, atrioventricular; ccTGA, congenitally corrected transposition of the great arteries; LV, left ventricle; MV, mitral valve; PA, pulmonary artery; RA, right atrium. Atypical exits from the AV node can also be targeted for ablation directly if these are not in the conventional fast pathway position on the septum, and the earliest atrial signal can be mapped. Future Directions and Conclusion Given the “corrected” nature of the anatomy in patients with ccTGA, this disorder often presents later in life, and often with an arrhythmia heralding that an underlying congenital lesion is present. The intrinsic deficiencies in the conduction system lend themselves to premature failure, and although permanent pacing is commonly required, the optimal initial pacing strategy remains to be defined. The obvious randomized trial of univentricular versus biventricular pacing is needed for those with ccTGA, yet before we enter the realm of randomized therapies for single congenital heart disease entities, registries and larger multicenter collaborative efforts are vital and more realistically within reach. Because right ventricular systole is more of a peristaltic motion and heavily reliant on left ventricular contraction,42 better imaging and processing modalities are vital if we are to support the systemic right ventricle optimally through pacing. Furthermore, the insights gained will likely also advance our understanding of the arrhythmogenicity of the failing right ventricle and risk stratification/prediction against sudden cardiac death. Finally it has become impossible to imagine a future of pacing without leadless systems and more importantly without biological therapies43, 44 that can restore automaticity or conduction so that current transvenous and epicardial systems become obsolete. This latter innovation is especially attractive for those patients with ccTGA, as they frequently require pacing at a much younger age than the conventional patient with AV block22 and therefore have many more years exposed to the risks of intravascular leads and generator replacement surgeries. Sources of Funding This work was supported by the Association for European Paediatric Cardiology (2014 Junior Scientific Research Grant), the French Society of Cardiology (2016 Bourse de Mobilité du Groupe de Rythmologie et Stimulation Cardiaque), and the Bettencourt‐Schueller Foundation (2016 Prix Jeune Chercheur) to Dr Baruteau. Disclosures None.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study.

              The objective of this study was to ascertain the prevalence and survival rate of children born with a heart defect. A total of 816, 569 children live-born between 1980 and 1990 in Bohemia (52,478 km(2), population 6.314 million, western Czech Republic) were followed up and those with suspected heart disease referred to a center. Echocardiography was done in all of them. All dead children were autopsied. Congenital heart disease was found in 5030 of 816, 569 children (6.16 per 1000 live births). The most frequent conditions were ventricular septal defect (41.59%), atrial septal defect (8.67%), aortic (7.77%) and pulmonary (5.81%) stenoses, transposition of the great arteries (5.39%), coarctation of the aorta (5.29%) and persistent ductus arteriosus (5.07%). The first week was survived by 92.46%, the first month by 89.14%, 6 months by 82.42%, and the first year of life by 80.02%, and 77.11% (95% CI 75. 91-78.31%) survived to age 15 years. The best prognosis was found in pulmonary stenosis (15-year survival 95.55%), atrial septal defect (92.04%), persistent ductus arteriosus (90.59%), ventricular septal defect (89.37%) and aortic stenosis (88.39%). The worst results were attained in hypoplastic left heart, truncus arteriosus and pulmonary atresia with intact ventricular septum. In conclusion, the prevalence of congenital heart disease was 6.16 per 1000 live births; 77.11% of patients survived to age 15 years.
                Bookmark

                Author and article information

                Contributors
                Journal
                HeartRhythm Case Rep
                HeartRhythm Case Rep
                HeartRhythm Case Reports
                Elsevier
                2214-0271
                23 March 2022
                July 2022
                23 March 2022
                : 8
                : 7
                : 471-474
                Affiliations
                []Heart & Vascular Institute, Penn State Health, Milton S. Hershey Medical Center, Hershey, Pennsylvania
                Author notes
                [∗∗ ] Address reprint requests and correspondence: Dr Ravi Shah, Heart & Vascular Institute, Penn State Health, Milton S. Hershey Medical Center, 500 University Dr, Hershey, PA 17033. Rshah6@ 123456pennstatehealth.psu.edu
                Article
                S2214-0271(22)00051-3
                10.1016/j.hrcr.2022.03.012
                9289060
                35860776
                b772bb22-1699-45ed-b145-52efdb6d74bd
                © 2022 Heart Rhythm Society. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Case Report

                leadless pacemaker,micra,av micra,congenitally corrected transposition of the great arteries,cctga,pacemaker infection

                Comments

                Comment on this article